Breaking News

Biden’s NIH pick will face slew of political questions; FDA approves first RSV vaccine

May 3, 2023
President Biden's presumed NIH pick, Monica Bertagnolli, will face a slew of increasingly political questions in her upcoming confirmation battle.
Jeff Chiu/AP

STAT+ | Biden's pick to lead NIH stares down an increasingly political litany of questions

Biden's presumed NIH pick Monica Bertagnolli will face a slew of increasingly political questions in her upcoming confirmation battle.

By Sarah Owermohle


FDA approves first RSV vaccine, a long-sought scientific achievement

A vaccine that was developed by Pfizer and aimed at the same demographic as GSK's Arexvy is expected to be approved by the end of the month.

By Helen Branswell


For Eli Lilly's head scientist, Alzheimer's results cap a 25-year scientific quest

Daniel Skovronsky, Eli Lilly's chief scientific officer, has been "pursuing the same enemy" for much of his career.

By Damian Garde



From left to right: STAT senior writer Matt Herper, Emily Whitehead, and her father, Tom Whitehead.
Sarah Gonzalez for STAT

Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity

After a decade as a symbol for the power of innovative medicines, childhood cancer survivor Emily Whitehead is ready for what's next.

By Jason Mast


Oft-prescribed beta blockers may not be wise for many heart patients

Two new studies suggest that it's time to question the common, long-term use of beta blockers for heart attack or heart failure patients.

By Elaine Chen


DEA will delay telemedicine restrictions for buprenorphine, Adderall, and other drugs

The proposal, which drew criticism, would have tightened access to drugs like buprenorphine for opioid addiction and Adderall for ADHD.

By Lev Facher


Opinion: Listen: Two medical residents debate their hospital's unionization drive

Will unionization help medical residents get better pay and hours, improving patient care? Or are unions overpromising?

By Torie Bosch


STAT+ | In early glimpse at data, Akili's video game shows positive results with adults with ADHD

Akili Interactive revealed top-line clinical trial results suggesting its video game treatment for ADHD is effective for adults.

By Mario Aguilar


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments